Show simple item record

Authordc.contributor.authorMiravitlles, Marc 
Authordc.contributor.authorMenezes, Ana 
Authordc.contributor.authorLópez Varela, María Victorina 
Authordc.contributor.authorCasas, Alejandro 
Authordc.contributor.authorUgalde, Luis 
Authordc.contributor.authorRamírez Venegas, Alejandra 
Authordc.contributor.authorMendoza Inzunza, Laura 
Authordc.contributor.authorLópez, Ana 
Authordc.contributor.authorWehrmeister, Fernando C. 
Authordc.contributor.authorSurmont, Filip 
Authordc.contributor.authorMontes de Oca, María 
Admission datedc.date.accessioned2018-07-30T16:17:10Z
Available datedc.date.available2018-07-30T16:17:10Z
Publication datedc.date.issued2018
Cita de ítemdc.identifier.citationRespiratory Medicine, 134 (2018): 62–69es_ES
Identifierdc.identifier.other10.1016/j.rmed.2017.11.018
Identifierdc.identifier.urihttps://repositorio.uchile.cl/handle/2250/150445
Abstractdc.description.abstractBackground: To analyse the relationship between symptoms at different times during the 24-hour day and outcomes in COPD. Methods: Observational cross-sectional study in a patients from 7 Latin American countries. The frequency of symptoms in the morning, at night and during the day was explored by means of standardised and validated questionnaires, and the relationship between symptoms and exacerbations and quality of life were investigated. Results: 734 patients (59.6% male, mean age 69.5 years, mean FEV1 50% predicted normal) were recruited. The most frequent symptoms during the day were dyspnea (75% of patients, of which 94% mild-moderate) and cough (72.2%, of which 93.4% mild-moderate). Highly symptomatic patients had a greater impairment in FEV1, more exacerbations and worse scores in COPD assessment test (CAT) and Body Mass Index, Obstruction, Dyspnoea and Exacerbations (BODEx) index (all p < 0.001). Morning symptoms were more frequent than night-time symptoms, particularly cough and dyspnoea (morning: 50.1% and 45.7%; night-time: 33.2% and 24.4%, respectively), and mostly rated as mild or moderate. Patients with morning or night-time symptoms presented with worse severity of daytime symptoms. There was a strong correlation between intensity of daytime with morning or night-time symptoms, as well as with CAT score (r = 0.715; p < 0.001), but a weak correlation with FEV1 (r = -0.205; p < 0.001). Conclusion: Morning symptoms were more frequent than night-time symptoms, and having either morning and/or night-time symptoms was associated with worse severity of daytime symptoms. Increased symptoms were strongly associated with worse quality of life and more frequent exacerbations, but weakly associated with airflow limitation.es_ES
Patrocinadordc.description.sponsorshipAstraZeneca Latin Americaes_ES
Lenguagedc.language.isoenes_ES
Publisherdc.publisherElsevieres_ES
Type of licensedc.rightsAttribution-NonCommercial-NoDerivs 3.0 Chile*
Link to Licensedc.rights.urihttp://creativecommons.org/licenses/by-nc-nd/3.0/cl/*
Sourcedc.sourceRespiratory Medicinees_ES
Keywordsdc.subjectSymptomses_ES
Keywordsdc.subjectQuality of lifees_ES
Keywordsdc.subjectExacerbationses_ES
Keywordsdc.subjectLatin Americaes_ES
Títulodc.titlePrevalence and impact of respiratory symptoms in a population of patients with COPD in Latin America: the LASSYC observational studyes_ES
Document typedc.typeArtículo de revista
Catalogueruchile.catalogadortjnes_ES
Indexationuchile.indexArtículo de publicación ISIes_ES


Files in this item

Icon

This item appears in the following Collection(s)

Show simple item record

Attribution-NonCommercial-NoDerivs 3.0 Chile
Except where otherwise noted, this item's license is described as Attribution-NonCommercial-NoDerivs 3.0 Chile